Democratizing human-relevant drug discovery through intelligent organoid analytics that accelerate therapeutic breakthroughs and unlock the mysteries of human biology.
Discover our mission to democratize human-relevant drug discovery
Learn about OrganoBit's journey and leadership team
Get in touch with our team
OrganoBit is revolutionizing drug discovery through intelligent organoid analytics that ensure reproducible, regulatory-ready results. We empower researchers with AI-powered platforms that bridge the gap between laboratory research and clinical applications, making human-relevant models accessible to biotechs worldwide.
Our three strategic missions—Disease Modeling Excellence, Neuroscience Innovation, and Biological Computing Frontier—address immediate commercial needs while positioning for long-term breakthrough discoveries. Through standardization, quality assurance, and pharmaceutical pathway support, we accelerate therapeutic breakthroughs where they matter most.
Built for FDA/EMA compliance from day one, our platforms address the urgent market need created by the FDA's 2025 animal testing phase-out initiative. We focus on empowering researchers rather than replacing them, providing the intelligent analytics needed to unlock previously undruggable targets.